Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Gutmann

Showing results (71-80 of 434) with videos related to

Pageof 44
Sort By:
Current Topics in Developmental Biology|February 8, 2011
Rethinking pediatric gliomas as developmental brain abnormalitiesNikkilina R Crouse, Sonika Dahiya, David H Gutmann
Pediatric Blood & Cancer|October 20, 2017
Neurofibromatosis type 1 and optic pathway glioma: Molecular interplay and therapeutic insightsSoumen Khatua, David H Gutmann, Roger J Packer
Brain Pathology (Zurich, Switzerland)|May 26, 2005
Meningothelial hyperplasia: a detailed clinicopathologic, immunohistochemical and genetic study of 11 casesArie Perry, Eriks A Lusis, David H Gutmann
Annual Review of Pathology|January 31, 2017
Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1Courtney L Monroe, Sonika Dahiya, David H Gutmann
Neuro-Oncology|January 1, 2017
Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunctionJoseph A Toonen, Yu Ma, David H Gutmann
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2004
Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-LRong Rong, Xiaoling Tang, David H Gutmann, et al.
Oncogene|January 16, 2004
Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene functionEzequiel I Surace, Carrie A Haipek, David H Gutmann
Oncology Times|October 4, 2021
Defining the Research Landscape for Dermal NeurofibromasLu Q LE, Robert A Kesterson, David H Gutmann
Glia|December 7, 2015
Pediatric gliomas as neurodevelopmental disordersSuzanne J Baker, David W Ellison, David H Gutmann
Developmental Medicine and Child Neurology|August 29, 2017
Neurodevelopmental disorders in children with neurofibromatosis type 1Alecia C Vogel, David H Gutmann, Stephanie M Morris
Pageof 44

Showing results (71-80 of 434) with videos related to

Sort By:
Pageof 44
Current Topics in Developmental Biology|February 8, 2011
Rethinking pediatric gliomas as developmental brain abnormalitiesNikkilina R Crouse, Sonika Dahiya, David H Gutmann
Pediatric Blood & Cancer|October 20, 2017
Neurofibromatosis type 1 and optic pathway glioma: Molecular interplay and therapeutic insightsSoumen Khatua, David H Gutmann, Roger J Packer
Brain Pathology (Zurich, Switzerland)|May 26, 2005
Meningothelial hyperplasia: a detailed clinicopathologic, immunohistochemical and genetic study of 11 casesArie Perry, Eriks A Lusis, David H Gutmann
Annual Review of Pathology|January 31, 2017
Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1Courtney L Monroe, Sonika Dahiya, David H Gutmann
Neuro-Oncology|January 1, 2017
Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunctionJoseph A Toonen, Yu Ma, David H Gutmann
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2004
Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-LRong Rong, Xiaoling Tang, David H Gutmann, et al.
Oncogene|January 16, 2004
Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene functionEzequiel I Surace, Carrie A Haipek, David H Gutmann
Oncology Times|October 4, 2021
Defining the Research Landscape for Dermal NeurofibromasLu Q LE, Robert A Kesterson, David H Gutmann
Glia|December 7, 2015
Pediatric gliomas as neurodevelopmental disordersSuzanne J Baker, David W Ellison, David H Gutmann
Developmental Medicine and Child Neurology|August 29, 2017
Neurodevelopmental disorders in children with neurofibromatosis type 1Alecia C Vogel, David H Gutmann, Stephanie M Morris
Pageof 44